Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

METTL21C is a potential pleiotropic gene for osteoporosis and sarcopenia acting through the modulation of the NF-?B signaling pathway.

METTL21C is a potential pleiotropic gene for osteoporosis and sarcopenia acting through the modulation of the NF-?B signaling pathway. J Bone Miner Res. 2014 Jul; 29(7):1531-1540.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.